Image: bausch.com
Holding a leadership position with Valeant Pharmaceuticals since 2014, Dr. Ari Kellen’s responsibilities extend to oversight of Latin America, U.S. Dermatology, and U.S. Bausch + Lomb businesses. Under Dr. Ari Kellen’s guidance, U.S. Bausch + Lomb maintains robust research and development capacities and stands at the leading edge of the industry.
In February 2016 Bausch + Lomb announced the introduction of ULTRA for Presbyopia contact lenses. These lenses are designed to take the place of silicone hydrogel lenses, which are not ideal for people who spend prolonged periods working on computers and other digital devices, especially if they experience vision issues or dryness of the eyes.
The innovative new daily disposable contacts combine the 3-Zone Progressive multifocal design with proprietary MoistureSeal® technologies that ensure comfort until the end of the day. Presbyopic patients enjoy a combination of predictable, easy-to-use lenses and a wearing experience that enables excellent distance, near, and intermediate vision. Simplified fitting guidelines streamline the process of delivering outstanding multi-focal vision.
Ari Kellen's WordPress Blog 